105 related articles for article (PubMed ID: 3776831)
1. Third party payment policies: design & impact.
Schondelmeyer SW
Am Pharm; 1986 Aug; NS26(8):41-5, 48-56, 63-8. PubMed ID: 3776831
[No Abstract] [Full Text] [Related]
2. Estimating a reasonable reimbursement for community pharmacies in third-party programs.
Carroll NV
Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189
[TBL] [Abstract][Full Text] [Related]
3. Profitability, third-party reimbursement, and access to community pharmacies.
Carroll NV; Miederhoff PA; Waters LW
Clin Ther; 1996; 18(4):703-15; discussion 702. PubMed ID: 8879898
[TBL] [Abstract][Full Text] [Related]
4. Case study using descriptive analysis to estimate hidden costs in processing third party prescriptions.
Herrier RN; Spencer JR; Davis CD
J Am Pharm Assoc (Wash); 2000; 40(5):658-65. PubMed ID: 11029847
[TBL] [Abstract][Full Text] [Related]
5. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
6. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
Kreling DH; Kirk KW
Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
[TBL] [Abstract][Full Text] [Related]
7. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
8. Effect of a change in third party reimbursement rate on prescription gross margin.
Ganther JM; Kreling DH
J Am Pharm Assoc (Wash); 1999; 39(3):346-52. PubMed ID: 10363461
[TBL] [Abstract][Full Text] [Related]
9. Assessing changes in third-party gross margin for a single community pharmacy.
Urick BY; Urmie JM; Doucette WR; McDonough RP
J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
[TBL] [Abstract][Full Text] [Related]
10. Savings from Canadian Internet pharmacies are limited.
Rothberg M
Ann Intern Med; 2006 Feb; 144(3):224; author reply 224-5. PubMed ID: 16461977
[No Abstract] [Full Text] [Related]
11. Who cares what it costs to dispense a Medicaid prescription?
Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
[TBL] [Abstract][Full Text] [Related]
12. Mail order pharmacy--savings or added cost?
Kaye T
Manag Care; 2003 Jun; 12(6):33-5. PubMed ID: 12854258
[No Abstract] [Full Text] [Related]
13. Dispensing in general practice. Overhaul system of reimbursement.
McCormack T
BMJ; 1993 Jun; 306(6894):1748. PubMed ID: 8343635
[No Abstract] [Full Text] [Related]
14. The market for retail pharmacies: a duopoly model.
Rossiter LF
Adv Health Econ Health Serv Res; 1982; 3():171-89. PubMed ID: 10257771
[No Abstract] [Full Text] [Related]
15. State and federal government mandates are changing the face of pharmacy management.
Giaquinta D
Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
[No Abstract] [Full Text] [Related]
16. Are online pharmacies good for your patients--and for you?
Lowes R
Med Econ; 2000 Jun; 77(11):77-80, 84-6. PubMed ID: 11010267
[No Abstract] [Full Text] [Related]
17. Factors influencing pharmacists' participation in third-party programmes.
Szeinbach SL
J Clin Pharm Ther; 1990 Aug; 15(4):241-5. PubMed ID: 2229204
[No Abstract] [Full Text] [Related]
18. Third party prescription programs: cost containment issues and strategies.
Richards JW
Am Pharm; 1985 Jul; NS25(7):28-35. PubMed ID: 4036802
[No Abstract] [Full Text] [Related]
19. Is Rx couponing a viable direct-marketing technique?
Spaulding CD; Josephs JW
Am Pharm; 1992 Jan; NS32(1):67-71. PubMed ID: 1570791
[No Abstract] [Full Text] [Related]
20. Summaries for patients. Price comparison for brand name drugs purchased through the Internet from Canada- and U.S.-based pharmacies.
Ann Intern Med; 2005 Sep; 143(6):I24. PubMed ID: 16172435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
